292
Views
9
CrossRef citations to date
0
Altmetric
Theme: Arrhythmias & Pacing - Review

ECG abnormalities and stroke incidence

&
Pages 853-861 | Published online: 10 Jan 2014

References

  • Go AS, Mozaffarian D, Roger VL et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2013 update: a report from the American Heart Association. Circulation 127(1), e6–e245 (2013).
  • Adams HP Jr, Bendixen BH, Kappelle LJ et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24(1), 35–41 (1993).
  • Goldstein LB, Bushnell CD, Adams RJ et al.; American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Epidemiology and Prevention; Council for High Blood Pressure Research, Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42(2), 517–584 (2011).
  • Folsom AR, Yatsuya H, Psaty BM, Shahar E, Longstreth WT Jr. Carotid intima–media thickness, electrocardiographic left ventricular hypertrophy, and incidence of intracerebral hemorrhage. Stroke 42(11), 3075–3079 (2011).
  • Kallmünzer B, Breuer L, Kahl N et al. Serious cardiac arrhythmias after stroke: incidence, time course, and predictors – a systematic, prospective analysis. Stroke 43(11), 2892–2897 (2012).
  • Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285(18), 2370–2375 (2001).
  • Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch. Intern. Med. 155(5), 469–473 (1995).
  • Rautaharju P, Rautaharju F. Investigative Electrocardiography in Epidemiological Studies and Clinical Trials. Springer, London, UK (2007).
  • Rosenberg MA, Samuel M, Thosani A, Zimetbaum PJ. Use of a noninvasive continuous monitoring device in the management of atrial fibrillation: a pilot study. Pacing Clin. Electrophysiol. 36(3), 328–333 (2013).
  • Lazzaro MA, Krishnan K, Prabhakaran S. Detection of atrial fibrillation with concurrent Holter monitoring and continuous cardiac telemetry following ischemic stroke and transient ischemic attack. J. Stroke Cerebrovasc. Dis. 21(2), 89–93 (2012).
  • Mittal S, Movsowitz C, Steinberg JS. Ambulatory external electrocardiographic monitoring: focus on atrial fibrillation. J. Am. Coll. Cardiol. 58(17), 1741–1749 (2011).
  • Harris K, Edwards D, Mant J. How can we best detect atrial fibrillation? J. R. Coll. Physicians Edinb. 42(Suppl. 18), 5–22 (2012).
  • D’Agostino RB, Wolf PA, Belanger AJ, Kannel WB. Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke 25(1), 40–43 (1994).
  • Miller DJ, Khan MA, Schultz LR et al. Outpatient cardiac telemetry detects a high rate of atrial fibrillation in cryptogenic stroke. J. Neurol. Sci. 324(1–2), 57–61 (2013).
  • Horstmann S, Rizos T, Güntner J et al. Does the STAF score help detect paroxysmal atrial fibrillation in acute stroke patients? Eur. J. Neurol. 20(1), 147–152 (2013).
  • Christensen H, Fogh Christensen A, Boysen G. Abnormalities on ECG and telemetry predict stroke outcome at 3 months. J. Neurol. Sci. 234(1–2), 99–103 (2005).
  • Watson T, Shantsila E, Lip GY. Mechanisms of thrombogenesis in atrial fibrillation: Virchow’s triad revisited. Lancet 373(9658), 155–166 (2009).
  • Guo Y, Lip GY, Apostolakis S. Inflammation in atrial fibrillation. J. Am. Coll. Cardiol. 60(22), 2263–2270 (2012).
  • Lim HS, Willoughby SR, Schultz C et al. Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm. J. Am. Coll. Cardiol. 61(8), 852–860 (2013).
  • Calkins H, Kuck KH, Cappato R et al.; Heart Rhythm Society Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm 9(4), 632–696.e21 (2012).
  • Furie KL, Kasner SE, Adams RJ et al.; American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Clinical Cardiology, and Interdisciplinary Council on Quality of Care and Outcomes Research. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42(1), 227–276 (2011).
  • Benjamin EJ, Chen PS, Bild DE et al. Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop. Circulation 119(4), 606–618 (2009).
  • Kamel H, Navi BB, Elijovich L et al. Pilot randomized trial of outpatient cardiac monitoring after cryptogenic stroke. Stroke 44(2), 528–530 (2013).
  • Schnabel RB, Sullivan LM, Levy D et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet 373(9665), 739–745 (2009).
  • Chamberlain AM, Agarwal SK, Folsom AR et al. A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] study). Am. J. Cardiol. 107(1), 85–91 (2011).
  • Alonso A, Krijthe BP, Aspelund T et al. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF Consortium. J. Am. Heart Assoc. 2(2), e000102 (2013).
  • Friberg L, Engdahl J, Frykman V, Svennberg E, Levin LÅ, Rosenqvist M. Population screening of 75- and 76-year-old men and women for silent atrial fibrillation (STROKESTOP). Europace 15(1), 135–140 (2013).
  • Soliman EZ, Alonso A, Goff DC Jr. Atrial fibrillation and ethnicity: the known, the unknown and the paradox. Future Cardiol. 5(6), 547–556 (2009).
  • Soliman EZ, Prineas RJ, Case LD, Zhang ZM, Goff DC Jr. Ethnic distribution of ECG predictors of atrial fibrillation and its impact on understanding the ethnic distribution of ischemic stroke in the Atherosclerosis Risk in Communities (ARIC) study. Stroke 40(4), 1204–1211 (2009).
  • Marini C, De Santis F, Sacco S et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke 36(6), 1115–1119 (2005).
  • Lip GY. Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why? Eur. Heart J. 34(14), 1041–1049 (2013).
  • Healey JS, Connolly SJ, Gold MR et al.; ASSERT Investigators. Subclinical atrial fibrillation and the risk of stroke. N. Engl. J. Med. 366(2), 120–129 (2012).
  • Conen D, Adam M, Roche F et al. Premature atrial contractions in the general population: frequency and risk factors. Circulation 126(19), 2302–2308 (2012).
  • Ofoma U, He F, Shaffer ML, Naccarelli GV, Liao D. Premature cardiac contractions and risk of incident ischemic stroke. J. Am. Heart Assoc. 1(5), e002519 (2012).
  • Engström G, Hedblad B, Juul-Möller S, Tydén P, Janzon L. Cardiac arrhythmias and stroke: increased risk in men with high frequency of atrial ectopic beats. Stroke 31(12), 2925–2929 (2000).
  • Yodogawa K, Seino Y, Ohara T et al. Prediction of atrial fibrillation after ischemic stroke using P-wave signal averaged electrocardiography. J. Cardiol. 61(1), 49–52 (2013).
  • Kronborg MB, Nielsen JC. Pacing in sinus node disease to prevent atrial fibrillation. Expert Rev. Cardiovasc. Ther. 10(7), 851–858 (2012).
  • Jensen TJ, Haarbo J, Pehrson SM, Thomsen B. Impact of premature atrial contractions in atrial fibrillation. Pacing Clin. Electrophysiol. 27(4), 447–452 (2004).
  • Lu TM, Tai CT, Hsieh MH et al. Electrophysiologic characteristics in initiation of paroxysmal atrial fibrillation from a focal area. J. Am. Coll. Cardiol. 37(6), 1658–1664 (2001).
  • Kohsaka S, Sciacca RR, Sugioka K, Sacco RL, Homma S, Di Tullio MR. Electrocardiographic left atrial abnormalities and risk of ischemic stroke. Stroke 36(11), 2481–2483 (2005).
  • Kabutoya T, Ishikawa S, Ishikawa J, Hoshide S, Kario K; JMS Cohort Study Investigators Group. P-wave morphologic characteristics predict cardiovascular events in a community-dwelling population. Ann. Noninvasive Electrocardiol. 17(3), 252–259 (2012).
  • Magnani JW, Johnson VM, Sullivan LM et al. P wave duration and risk of longitudinal atrial fibrillation in persons = 60 years old (from the Framingham Heart Study). Am. J. Cardiol. 107(6), 917.e1–921.e1 (2011).
  • Jain A, Tandri H, Dalal D et al. Diagnostic and prognostic utility of electrocardiography for left ventricular hypertrophy defined by magnetic resonance imaging in relationship to ethnicity: the Multi-Ethnic Study of Atherosclerosis (MESA). Am. Heart J. 159(4), 652–658 (2010).
  • Schirmer H, Lunde P, Rasmussen K. Prevalence of left ventricular hypertrophy in a general population; The Tromsø Study. Eur. Heart J. 20(6), 429–438 (1999).
  • Desai CS, Ning H, Lloyd-Jones DM. Competing cardiovascular outcomes associated with electrocardiographic left ventricular hypertrophy: the Atherosclerosis Risk in Communities Study. Heart 98(4), 330–334 (2012).
  • Levy D. Left ventricular hypertrophy. Epidemiological insights from the Framingham Heart Study. Drugs 35(Suppl. 5), 1–5 (1988).
  • Cuspidi C, Sala C, Negri F, Mancia G, Morganti A; Italian Society of Hypertension. Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies. J. Hum. Hypertens. 26(6), 343–349 (2012).
  • Sacco RL, Benjamin EJ, Broderick JP et al. American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors. Stroke 28(7), 1507–1517 (1997).
  • Subramaniam V, Lip GY. Hypertension to heart failure: a pathophysiological spectrum relating blood pressure, drug treatments and stroke. Expert Rev. Cardiovasc. Ther. 7(6), 703–713 (2009).
  • Unverzagt FW, McClure LA, Wadley VG et al. Vascular risk factors and cognitive impairment in a stroke-free cohort. Neurology 77(19), 1729–1736 (2011).
  • Chambless LE, Heiss G, Shahar E, Earp MJ, Toole J. Prediction of ischemic stroke risk in the Atherosclerosis Risk in Communities Study. Am. J. Epidemiol. 160(3), 259–269 (2004).
  • Goldstein DS. The electrocardiogram in stroke: relationship to pathophysiological type and comparison with prior tracings. Stroke 10(3), 253–259 (1979).
  • Okin PM. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients. J. Electrocardiol. 42(6), 584–588 (2009).
  • Agabiti-Rosei E, Muiesan ML, Salvetti M. New approaches to the assessment of left ventricular hypertrophy. Ther. Adv. Cardiovasc. Dis. 1(2), 119–128 (2007).
  • Barrabés JA, Figueras J, Cortadellas J, Lidón RM, Ibars S. Usefulness of electrocardiographic and echocardiographic left ventricular hypertrophy to predict adverse events in patients with a first non-ST-elevation acute myocardial infarction. Am. J. Cardiol. 103(4), 455–460 (2009).
  • Schmieder RE, Martus P, Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies. JAMA 275(19), 1507–1513 (1996).
  • Verdecchia P, Angeli F, Borgioni C et al. Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis. Am. J. Hypertens. 16(11 Pt 1), 895–899 (2003).
  • Pierdomenico SD, Cuccurullo F. Risk reduction after regression of echocardiographic left ventricular hypertrophy in hypertension: a meta-analysis. Am. J. Hypertens. 23(8), 876–881 (2010).
  • Costanzo P, Savarese G, Rosano G et al. Left ventricular hypertrophy reduction and clinical events. A meta-regression analysis of 14 studies in 12,809 hypertensive patients. Int. J. Cardiol. doi:10.1016/j.ijcard.2012.06.084 (2012) (Epub ahead of print).
  • Simpson RJ Jr, Cascio WE, Schreiner PJ, Crow RS, Rautaharju PM, Heiss G. Prevalence of premature ventricular contractions in a population of African–Americans and white men and women: the Atherosclerosis Risk in Communities (ARIC) study. Am. Heart J. 143(3), 535–540 (2002).
  • Agarwal SK, Heiss G, Rautaharju PM, Shahar E, Massing MW, Simpson RJ Jr. Premature ventricular complexes and the risk of incident stroke: the Atherosclerosis Risk In Communities (ARIC) Study. Stroke 41(4), 588–593 (2010).
  • Watanabe H, Tanabe N, Makiyama Y et al. ST-segment abnormalities and premature complexes are predictors of new-onset atrial fibrillation: the Niigata preventive medicine study. Am. Heart J. 152(4), 731–735 (2006).
  • Agarwal SK, Simpson RJ Jr, Rautaharju P et al. Relation of ventricular premature complexes to heart failure (from the Atherosclerosis Risk In Communities [ARIC] Study). Am. J. Cardiol. 109(1), 105–109 (2012).
  • Kuroki K, Tada H, Seo Y et al. Prediction and mechanism of frequent ventricular premature contractions related to haemodynamic deterioration. Eur. J. Heart Fail. 14(10), 1112–1120 (2012).
  • Bhushan M, Asirvatham SJ. The conundrum of ventricular arrhythmia and cardiomyopathy: which abnormality came first? Curr. Heart Fail. Rep. 6(1), 7–13 (2009).
  • Beaufort-Krol GC, Dijkstra SS, Bink-Boelkens MT. Natural history of ventricular premature contractions in children with a structurally normal heart: does origin matter? Europace 10(8), 998–1003 (2008).
  • Adams JC, Srivathsan K, Shen WK. Advances in management of premature ventricular contractions. J. Interv. Card. Electrophysiol. 35(2), 137–149 (2012).
  • Kanei Y, Friedman M, Ogawa N, Hanon S, Lam P, Schweitzer P. Frequent premature ventricular complexes originating from the right ventricular outflow tract are associated with left ventricular dysfunction. Ann. Noninvasive Electrocardiol. 13(1), 81–85 (2008).
  • Baman TS, Lange DC, Ilg KJ et al. Relationship between burden of premature ventricular complexes and left ventricular function. Heart Rhythm 7(7), 865–869 (2010).
  • Simpson RJ Jr, Cascio WE, Crow RS, Schreiner PJ, Rautaharju PM, Heiss G. Association of ventricular premature complexes with electrocardiographic-estimated left ventricular mass in a population of African–American and white men and women (The Atherosclerosis Risk in Communities). Am. J. Cardiol. 87(1), 49–53 (2001).
  • Worthington JM, Gattellari M, Leung DY. ‘Where there’s smoke.’: are premature ventricular complexes a new risk factor for stroke? Stroke 41(4), 572–573 (2010).
  • Pratt CM, Moye LA. The Cardiac Arrhythmia Suppression Trial: background, interim results and implications. Am. J. Cardiol. 65(4), 20B–29B (1990).
  • Soliman EZ, Howard G, Cushman M et al. Prolongation of QTc and risk of stroke: the REGARDS (REasons for Geographic and Racial Differences in Stroke) study. J. Am. Coll. Cardiol. 59(16), 1460–1467 (2012).
  • Malik M, Camm AJ. Components of heart rate variability–what they really mean and what we really measure. Am. J. Cardiol. 72(11), 821–822 (1993).
  • Binici Z, Mouridsen MR, Køber L, Sajadieh A. Decreased nighttime heart rate variability is associated with increased stroke risk. Stroke 42(11), 3196–3201 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.